MHRA sets out closer FDA alignment and AI agenda at AdvaMed

Other regulatory action · MHRA

19 October 2026

The MHRA used AdvaMed to promote its 2030 strategy, including wider reliance on decisions by trusted regulators such as FDA, a planned Centre for AI and Digital Health and a US liaison post; no implementation dates were given.

Type: Other regulatory action
Company: MHRA
Device: Medical devices and AI as a medical device
Date: 19 October 2026
Jurisdiction: UK
Classification: UK policy
Source: GOV.UK (MHRA press release)

Official source →Source checked

Other regulatory actions

← All of Regulatory Watch

Clinical PracticeLiterature Watch Patent Watch Books Guideline Library Case of the Month Guest Editor Rare Diseases Report a Device Problem Safety in Focus Secure Messaging Viewing Scans (DICOM)Measurement Apps Coding & Reimbursement Veterinary Spine Spine Podcasts Get Involved

Training & CareersTrainee Hub Fellowships Jobs Get Involved Spine Podcasts

ResearchTrials Watch Spine Registries Spine Journals Funding Calls Spine Podcasts

Medtech & InnovationIndustry Roundup Product Developments Regulatory Watch Implant Systems How It's Made AI & Emerging Tech Off Duty: Podcasts for Reps Spine Theatre Builder Spine Markets Coding & Reimbursement

Meetings & SocietiesConferences & Courses Abstract Deadlines Spine Societies Worldwide

Spine Team & Allied HealthFor the Spine Team Spine Anaesthesia Neuromonitoring Pain Medicine Theatre Safety Halo Traction Spine Podcasts Get Involved

WellbeingHealth & Nutrition Body & Mind Supplements Mental Health for Clinicians

About & editorial policy Feedback Weekly alert sign-up Back issues Privacy notice Don't count my visits Legal notice Corrections for companies Advertise with us Partner Offers Search Use as an app

Spinal Frontiers is published by NSpine Limited, registered in England and Wales (company no. 08362634), 14 Park Row, Nottingham NG1 6GR, United Kingdom. Every item is summarised in our own words and links to its original source. Listings are a selection made at NSpine's editorial discretion and are not exhaustive; inclusion is not an endorsement, and omission implies nothing. Sponsors and advertisers have no influence on what we cover. Nothing here is medical, legal or financial advice. Spotted an error or a broken link? Email spinalfrontiers@nspine.com, or use the feedback page.

Spinal Frontiers is a trademark of NSpine GmbH.

Information only, summarised from third-party sources: not medical, legal, regulatory or financial advice. Full disclaimer.